Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-19-044917
Filing Date
2019-09-17
Accepted
2019-09-17 16:48:53
Documents
3
Period of Report
2019-10-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A tv529467-pre14a.htm PRE 14A 249408
2 GRAPHIC tv529467_pc1.jpg GRAPHIC 507403
3 GRAPHIC tv529467_pc2.jpg GRAPHIC 492165
  Complete submission text file 0001144204-19-044917.txt   1626968
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-50626 | Film No.: 191097532
SIC: 2834 Pharmaceutical Preparations